- Home
- GOSS vs NGS Comparison
GOSS vs NGS Comparison
Compare GOSS & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOSS | NGS |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.8M | 420.9M |
| IPO Year | 2019 | 2002 |
Fundamental Metrics
Financial Performance| Metric | GOSS | NGS |
|---|---|---|
| Price | $3.56 | $32.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $8.60 | ★ $35.67 |
| AVG Volume (30 Days) | ★ 3.2M | 97.5K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | N/A | ★ 14.85 |
| EPS | N/A | ★ 1.47 |
| Revenue | $44,051,000.00 | ★ $166,824,000.00 |
| Revenue This Year | N/A | $9.50 |
| Revenue Next Year | $6.41 | $13.88 |
| P/E Ratio | ★ N/A | $22.07 |
| Revenue Growth | N/A | ★ 9.53 |
| 52 Week Low | $0.76 | $16.73 |
| 52 Week High | $3.87 | $33.82 |
Technical Indicators
Market Signals| Indicator | GOSS | NGS |
|---|---|---|
| Relative Strength Index (RSI) | 61.72 | 59.87 |
| Support Level | $3.53 | $31.70 |
| Resistance Level | $3.87 | $33.72 |
| Average True Range (ATR) | 0.23 | 1.06 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 64.80 | 60.98 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.